2016년 심혈관 춘계통합학술대회 제8회 아시아·태평양 심부전 학술대회
- 참여 학회
- 대한심장학회, 대한심혈관중재학회, 한국심초음파학회, 한국지질·동맥경화학회
- 상세내용
-
2016 Annual Spring Scientific Conference of the KSC in conjunction with KSIC, KSE, and KSLA & The 8th Asian Pacific Congress of Heart Failure
장소 : HICO, Gyeongju, Korea
날짜 : April 15 - 16, 2016
- 슬로건
- One Heart, One Life
학회별 일정
| Vascular | April 20, 09:30-11:00 Rm.101 | |
|---|---|---|
| Inflammation & Atherosclerosis | ||
| Chairpersons | 하종원, 정해억 | |
| Panel | 강시혁, 김응주, 박재형 | |
| 09:30-09:45 | Clinical Evidence of Association between Inflammation and CVD | 이선기/한림의대 |
| 09:45-10:00 | Conventional Anti-Inflammatory Therapy for Atherosclerosis | 박진선/아주의대 |
| 10:00-10:15 | Target for Anti-Inflammatory Therapy in Immune Cell & Cytokine | 정혜문/경희의대 |
| 10:15-10:30 | Anti-Inflammatory Therapy with Canakinumab for Atherosclerosis(CANTOS Trial) | 이찬주/연세의대 |
| 10:30-10:45 | Previous Trials of Anti-Inflammatory Therapy, before CANTOS Trial | 이해영/서울의대 |
| 10:45-11:00 | Discussion | |
| Myocardial Infarction 1 | April 20, 09:30-11:00 Rm.201 | |
|---|---|---|
| Beyond Evidence-Based 'To Do and Not to Do' | ||
| Chairpersons | 채성철, 정명호 | |
| Panel | 김동기, 박종선, 배장환, 이장훈, 장기육 | |
| 09:30-09:50 | Time Target in STEMI: D2B Time or FMC to Wire Crossing? | 윤창환/서울의대 |
| 09:50-10:10 | Optimizing DAPT Duration after AMI: Evidence-Based, Precision, or Personalized Medicine? |
박용휘/경상의대 |
| 10:10-10:30 | Complete Immediate Revascularization in Primary PCI Is The New Standard of Care? | 이주명/성균관의대 |
| 10:30-10:50 | Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA); Medical Therapy and Outcome |
윤혁준/계명의대 |
| 10:50-11:00 | Discussion | |
| Women Heart Disease | April 20, 11:10-12:40 Rm.101 | |
|---|---|---|
| Aging & Heart in Women | ||
| Chairpersons | 심완주, 윤호중 | |
| Panel | 김학령, 신미승, 오세일, 유철웅 | |
| 11:10-11:30 | Frailty & Sarcopenia in Women | 김광일/서울의대 |
| 11:30-11:50 | Obesity and Visceral Fat in Women | 박성미/고려의대 |
| 11:50-12:10 | Atrial Fibrillation - What Are Worse in Women | 유희태/연세의대 |
| 12:10-12:30 | Degenerative Aortic Stenosis & TAVI in Elder Women | 박덕우/울산의대 |
| 12:30-12:40 | Discussion | |
| Hypertension | April 20, 11:10-12:40 Rm.103 | |
|---|---|---|
| Unresolved Issues in HT | ||
| Chairpersons | 김철호, 조명찬 | |
| 11:10-11:35 | How Should We Measure Blood Pressure in the Post SPRINT, Post Mercury Sphygmomanometer Era |
신진호/한양의대 |
| 11:35-12:00 | Efficacy of Blood Pressure Control in Stage 1, Low Risk Hypertension | 박성하/연세의대 |
| 12:00-12:25 | Updates on Device Therapy for Resistant Hypertension | 장기육/가톨릭의대 |
| 12:25-12:40 | Discussion | |
| Myocardial Infarction 2 | April 20, 11:10-12:40 Rm.201 | |
|---|---|---|
| Emerging Lanscape | ||
| Chairpersons | 김종진, 김효수 | |
| Panel | 김현국, 이상엽, 조진만, 허승호, 황진용 | |
| 11:10-11:30 | Rehabilitation Following Myocardial Infarction | 이종영/성균관의대 |
| 11:30-11:50 | Sudden Cardiac Death Early after AMI: Risk Stratification Methods and Primary Prevention |
한성욱/계명의대 |
| 11:50-12:10 | Needle to Scalpel for Myocardial Infarction: Surgeon's Point of View | 김준범/울산의대 |
| 12:10-12:30 | Mood and Mind after Myocardial Infarction | 김재민/전남의대 |
| 12:30-12:40 | Discussion | |
| Scientific Session [MSD] | April 20, 12:40-13:20 Rm.101 | |
|---|---|---|
| The Latest Updates on the Management of Patients with CVD | ||
| Chairpersons | 정욱성, 권현철 | |
| 12:40-13:00 | Indispensable Role of Ezetimibe/Atorvastatin Combination Therapy in ACS/CHD Patients | 한기훈/울산의대 |
| 13:00-13:20 | Re-evaluate Diabetes Treatment Focusing on the CV Risk Patients | 김혜순/계명의대 |
| Scientific Session [Boryung] | April 20, 12:40-13:20 Rm.103 | |
|---|---|---|
| Hypertension : Update 2018 | ||
| Chairpersons | 승기배, 하종원 | |
| 12:40-13:00 | Evaluation the Antihypertensive Efficacy of Fimasartan vs. Valsartan Monotherapy | 정우백/가톨릭의대 |
| 13:00-13:20 | The Next Treatment Strategy for Hypertension Patient | 김병극/연세의대 |
| Scientific Session [Hanmi] | April 20, 12:40-13:20 Rm.105 | |
|---|---|---|
| Optimal CVD Control with Triple Therapy Based on "Amlodipine/Losartan" FDC | ||
| Chairpersons | 차태준, 홍범기 | |
| 12:40-13:00 | Evidence-based Approach for Intensive BP Control | 김응주/고려의대 |
| 13:00-13:20 | Towards Optimal Management of CV Risk in Hypertensive Patients with Dyslipidemia | 박우정/한림의대 |
| Scientific Session [Pfizer] | April 20, 12:40-13:20 Rm.107 | |
|---|---|---|
| Secondary CV Prevention: Where We Are Now? | ||
| Chairpersons | 탁승제, 김효수 | |
| 12:40-13:00 | The Latest Updates on the Management of Patients with CHD | 남창욱/계명의대 |
| 13:00-13:20 | Personalized Lipid-Lowering Therapy in High Risk Patients | 이상학/연세의대 |
| Scientific Session [Bayer] | April 20, 12:40-13:20 Rm.201 | |
|---|---|---|
| Confidence through Real World Experience with Rivaroxaban | ||
| Chairpersons | 김영훈, 전은석 | |
| 12:40-13:00 | The First Prospective, Observational Study with Rivaroxaban in NVAF Patients in Asia: XANAP |
심재민/고려의대 |
| 13:00-13:20 | Renal Outcomes in Anticoagulation Treatment with Rivaroxaban | 이기홍/전남의대 |
| Scientific Session [BMS] | April 20, 12:40-13:20 Rm.202 | |
|---|---|---|
| Choose the Right NOAC to Protect AF Patients from Stroke and Bleedings | ||
| Chairpersons | 성인환, 신동구 | |
| 12:40-13:00 | Patient in Focus: What Is the Role of Apixaban in Managing Elderly/CKD Patient with AF |
박형욱/전남의대 |
| 13:00-13:20 | Patient in Focus: What Is the Role of Apixaban in Managing AF Patient with Coronary Artery Disease |
홍순준/고려의대 |
| [English Session] Memorial Lecture | April 20, 13:40-14:30 Rm.202 | |
|---|---|---|
| Chairperson | Seung-Jung Park | |
| 13:40-13:55 | In Memory of Suh, Soon Kyu | Wan Joo Shim/Korea Univ., Korea |
| 13:55-14:25 | Cardiac Repair after Myocardial Infarction | Steven Houser/Temple Univ., USA |
| Heart Failure 1 | April 20, 14:30-16:00 Rm.103 | |
|---|---|---|
| Management of Advanced Heart Failure | ||
| Chairpersons | 유규형, 강석민 | |
| Panel | 김명아, 신미승, 조현재, 최진오 | |
| 14:30-14:45 | Cardiorenal Syndrome | 오재원/연세의대 |
| 14:45-15:00 | Diuretic Resistance: How to Manage? | 이주희/충북의대 |
| 15:00-15:15 | Hyponatremia in HF | 박진주/서울의대 |
| 15:15-15:30 | RV Failure in the Patients with Left-Sided HF | 윤종찬/한림의대 |
| 15:30-16:00 | Discussion | |
| [English Session] Cardiometabolic Syndrome | April 20, 16:10-17:40 Rm.103 | |
|---|---|---|
| Crosstalk in Cardiometabolic Syndrome | ||
| Chairpersons | Hong Seog Seo, Kwang Kon Koh | |
| Panel | Sang-Hyun Kim, Ki Chul Sung, Il Suk Sohn, Sang-Ho Jo | |
| 16:10-16:30 | IRAK-1 Phosphorylates IRS-1 on Ser24: Crosstalk Relevant to the Pathophysiology of Cardiometabolic Syndrome |
Michael J. Quon/University of Maryland, USA |
| 16:30-16:40 | Discussion | |
| 16:40-16:55 | Gut Microbiota and Metabolic Disorders | Seong-Eun Kim/Ewha Womans Univ., Korea |
| 16:55-17:10 | Dynamic Crosstalk between Immune System and Cardiometabolic Diseases | Jong-Chan Youn/Hallym Univ., Korea |
| 17:10-17:25 | Cardiometabolic Crosstalk in Obesity-Related Hypertension | Sungha Park/Yonsei Univ., Korea |
| 17:25-17:40 | Discussion | |
| Smart Healthcare | April 20, 16:10-17:40 Rm.202 | |
|---|---|---|
| Application of Smart Healthcare in Cardiovascular Disease | ||
| Chairpersons | 박승우, 김용진 | |
| 16:10-16:35 | Development of Medical Big Data Platform | 박경민/울산의대 |
| 16:35-17:00 | Retinal Damage as the Window to Cardiovascular Organ Damage: Use of Machine Learning of Retinal Damage to Predict the Presence of Cardiovascular Target Organ Damage |
임형택/연세의대 |
| 17:00-17:25 | Remote Monitoring of Heart Failure Patients | 박진주/서울의대 |
| 17:25-17:40 | Discussion | |
| Imaging | April 21, 09:00-10:30 Rm.101 | |
|---|---|---|
| Multimodality Imaging in Valvular Heart Disease and Valvular Calcification | ||
| Chairpersons | 송재관, 강원준 | |
| 09:00-09:20 | Role of Imagings in VHD Management | 이상철/성균관의대 |
| 09:20-09:40 | Initial Assessment of VHD with Echocardiography | 윤연이/서울의대 |
| 09:40-10:00 | The Role of CT/MRI in VHD | 양동현/울산의대 |
| 10:00-10:20 | The Assessment of Valvular Inflammation/Calcification Using PET | 팽진철/서울의대 |
| [English Session] Epidemiology | April 21, 09:00-10:30 Rm.103 | |
|---|---|---|
| Epidemiologic Research Using National Big Data | ||
| Chairpersons | Sang Hong Baek, Boyoung Joung | |
| Panel | Jang-Whan Bae, Ki Chul Sung, Song Vogue Ahn, Jin Yong Hwang | |
| 09:00-09:20 | CVD Epidemiologic Studies Using The UK Health Improvement Network (THIN) Database | G. Neil Thomas/ The University of Birmingham, UK |
| 09:20-09:35 | CVD Burden in Cancer Patients: National Health Insurance Service-National Sample Cohort (NHIS-NSC) |
Jong-Chan Youn/Hallym Univ., Korea |
| 09:35-09:50 | Long-Term Risk Factor Changes and CVD: National Health Insurance Service-Health Screening Cohort (NHIS-HEALS) |
Hyeon Chang Kim/Yonsei Univ., Korea |
| 09:50-10:05 | CVD Event Ascertainment with Health Insurance Claims and Hospital Records | Min Ho Shin/ Chonnam National Univ., Korea |
| 10:05-10:30 | Discussion | |
| Adult Congenital Heart Disease | April 21, 09:00-10:30 Rm.107 | |
|---|---|---|
| Chairpersons | 고재곤, 박승우 | |
| Panel | 김지나, 송미경, 조화진 | |
| 09:00-09:15 | Risk Factors for Cerebrovascular Problem in ACHD | 정진만/고려의대 |
| 09:15-09:30 | Cardiac Rehabilitation with Daily Activity and Exercise in ACHD | 허준/성균관의대 |
| 09:30-09:45 | Hematologic Issues of Eisenmenger Syndrome in ACHD | 김성호/세종병원 |
| 09:45-10:00 | Congestive Hepatopathy in ACHD | 백재숙/울산의대 |
| 10:00-10:15 | How to Prevent and Manage Infectious Endocarditis in ACHD | 김성혜/한림의대 |
| 10:15-10:30 | Discussion | |
| Health Policy | April 21, 10:40-12:10 Rm.101 | |
|---|---|---|
| Regional Variability in Cardio-Vascular Health Care Delivery | ||
| Chairpersons | 오동진, 박현영 | |
| Panel | 김병옥, 김혜래, 문건웅, 정우영 | |
| 10:40-11:00 | Regional Disparity in Survival Outcomes of Acute Myocardial Infarction | 배장환/충북의대 |
| 11:00-11:20 | Regional Variation in Emergency Service Use in Cardio-Vascular Diseases | 김윤/서울의대 |
| 11:20-11:40 | 심뇌혈관질환관리 종합계획-Implementation of a Regional Heathcare Network | 김남순/보건사회연구원 |
| 11:40-12:00 | Role of Primary Stroke Center in Improving Accessiblity in the Rural Setting | 장민욱/한림의대 |
| Cardiac Surgery | April 21, 10:40-12:10 Rm.103 | |
|---|---|---|
| Current State-of-the-Art of Coronary Artery Surgery | ||
| Chairpersons | 유경종, 윤정섭 | |
| 10:40-10:55 | SYNTAX, EXCEL, NOBLE and Current Comparative Studies about PCI vs. CABG | 이기종/연세의대 |
| 10:55-11:10 | Total Arterial Grafting (TAR): Should We Apply TAR to All Patients? | 조광리/세종병원 |
| 11:10-11:25 | On-Pump vs. Off-Pump CABG: Which Is Better Now? | 윤영남/연세의대 |
| 11:25-11:40 | Can Composite Grafting Supply The Entire Heart? | 황호영/서울의대 |
| 11:40-11:50 | How to Improve Surgical Results : Prevention of Stroke after CABG | 강준규/가톨릭의대 |
| 11:50-12:00 | How to Improve Surgical Results : Prevention of Atrial Fibrillation after CABG | 이승현/연세의대 |
| 12:00-12:10 | Discussion | |
| Pediatric Cardiology | April 21, 10:40-12:10 Rm.107 | |
|---|---|---|
| Coronary Artery Problems | ||
| Chairpersons | 김영휘, 최재영 | |
| Panel | 은영민, 이상윤, 하기수 | |
| 10:40-10:55 | Congenital Abnormality of Coronary Artery with Long-Term Outcomes (Origin, ALCAPA, Fistula) |
이형두/부산의대 |
| 10:55-11:10 | Combined Coronary Problem with Congenital Heart Disease - TOF DORV TGV 등 | 이재영/가톨릭의대 |
| 11:10-11:25 | Acquired Coronary Problem in Children and Adolescent | 김기범/서울의대 |
| 11:25-11:40 | Imaging of Coronary Problem in Children | 정조원/연세의대 |
| 11:40-11:55 | Intervention of Coronary Problem in Children | 장소익/세종병원 |
| 11:55-12:10 | Discussion | |
| [Joint Session] Imaging & Intervention | April 21, 10:40-12:10 Rm.201 | |
|---|---|---|
| Treatment of Coronary Artery Disease: 40 Years of PCI, Where Next? | ||
| Chairpersons | 송재관, 한규록 | |
| Panel | 김영학, 김중선, 김형관, 남창욱, 신성희, 이상철, 정해억, 조병렬 | |
| 40 Years of PCI: We Should Know Each Other!!! | ||
| 10:40-10:55 | PCI as Contributor to CV Outcome Improvements | 안영근/전남의대 |
| 10:55-11:10 | CV Imaging as Contributor to CV Outcome Improvements | 홍그루/연세의대 |
| 11:10-11:25 | Discussion | |
| 40 Years of PCI: Invasive vs. Non-Invasive Contibution in the Management of Coronary Disease in the Contemporary Era | ||
| 11:25-11:40 | Interventionist View: PCI Guided by FFR and IVUS | 구본권/서울의대 |
| 11:40-11:55 | Imaging Specialist View: Viablity Assessment with CV Imaging; Echo, Nuclear Imaging, CMR, and More |
김형섭/계명의대 |
| 11:55-12:10 | Discussion | |
| Scientific Session [Daiichisankyo-Daewoong] | April 21, 12:10-12:50 Rm.103 | |
|---|---|---|
| Achieving Best Outcomes for Patients with Cardiovascular Disease with Olmesartan and Edoxaban | ||
| Chairpersons | 최기준, 강석민 | |
| 12:10-12:30 | Improving Management of Hypertension | 손일석/경희의대 |
| 12:30-12:50 | Engaging with the Real-World: NOACs in Korea Focusing on Edoxaban | 최의근/서울의대 |
| Scientific Session [Takeda] | April 21, 12:10-12:50 Rm.105 | |
|---|---|---|
| New ARB, Edarbi for New Hypertensive Patients | ||
| Chairpersons | 조명찬, 김동수 | |
| 12:10-12:40 | New ARB, Edarbi for New Hypertensive Patients | 김용진/서울의대 |
| Scientific Session [Samjin] | April 21, 12:10-12:50 Rm.107 | |
|---|---|---|
| Risk Management of Cardiovascular and Cerebrovascular Disease and Treatment of NOAC | ||
| Chairpersons | 전동운, 채인호 | |
| 12:10-12:30 | 고혈압환자에서 심혈관질환의 위험도 관리 | 이준희/한림의대 |
| 12:30-12:50 | Real-World Evidence of NOACs on Stroke Prevention on AF Patients: Where Are We Now? |
이소령/순천향의대 |
| Diamond Session [Bayer] | April 21, 12:10-12:50 Rm.201 | |
|---|---|---|
| Protecting Multi-Morbid Patients with NVAF through Responsible Use of Rivaroxaban | ||
| Chairpersons | 한규록, 김대경 | |
| 12:10-12:30 | What’s Your Choice of NOAC for Patients with NAVF Undergoing PCI? | 한주용/성균관의대 |
| 12:30-12:50 | How Do You Appropriately Treat Multi-Morbid Patients with NVAF? | 박형섭/계명의대 |
| Diamond Session [BMS] | April 21, 12:10-12:50 Rm.202 | |
|---|---|---|
| How Inconsistent Is NOAC Dosing in AF? | ||
| Chairpersons | 김남호, 온영근 | |
| 12:10-12:30 | Appropriateness of NOAC Dosing to Prevent Stroke and Bleedings in AF | 김태훈/연세의대 |
| 12:30-12:50 | Choosing the Right NOAC at the Right Dose for the Right Patients | 김유리/가톨릭의대 |
| Heart Failure 2 | April 21, 13:10-14:30 Rm.103 | |
|---|---|---|
| Updates in Management of HF | ||
| Chairpersons | 채성철, 최동주 | |
| Panel | 박대균, 신미승, 홍석근 | |
| 13:10-13:25 | Recent Updates in HF Care | 김응주/고려의대 |
| 13:25-13:40 | ICD for Primary Prevention of Nonischemic Cardiomyopathy | 이상언/울산의대 |
| 13:40-13:55 | Management of HF with Recovered EF | 조재영/전남의대 |
| 13:55-14:10 | How to Improve Quality of Care of HF | 유병수/연세의대 |
| 14:10-14:30 | Discussion | |
| [English Session] Basic Research 1 | April 21, 13:10-14:30 Rm.105 | |
|---|---|---|
| Inflammatory Signaling in Heart and Vascular Disease | ||
| Chairpersons | Donghoon Choi, Youngkeun Ahn | |
| Panel | Young Mi Park, Jaewon Oh, Sang-Hak Lee, Seung Hwan Han | |
| 13:10-13:25 | SREBP1 and Inflammatory Signaling | Yumiko Oishi/Nippon Medical School |
| 13:25-13:40 | The Roles of Myeloid Cells in Atherosclerosis | Jae Hoon Choi/Hanyang Univ., Korea |
| 13:40-13:55 | A Heart-brain-kidney Network Controls Adaptation to Cardiac Stress through Tissue Macrophage Activation |
Katsuhito Fujiu/Tokyo Univ., Japan |
| 13:55-14:10 | Role of HDAC in Vascular Calcification and Cardiovascular Disease | Gwang Hyeon Eom/ Chonnam National Univ., Korea |
| 14:10-14:30 | Discussion | |
| [English Session] Pediatric Cardiac Surgery 1 | April 21, 13:10-14:30 Rm.107 | |
|---|---|---|
| Coronary Artery Anomalies | ||
| Chairpersons | Young Hwan Park, Myung Chul Hyun | |
| Panel | Jae Gun Kwak, Chun Soo Park, Hong Ju Shin | |
| 13:10-13:20 | Surgical Options for Congenital Coronary Anomalies | Han Ki Park/Yonsei Univ., Korea |
| 13:20-13:30 | Difficult Coronaries in Arterial Switch Operation | Woong-Han Kim/ Seoul National Univ., Korea |
| 13:30-13:40 | Pediatric CABG | Ji-Hyuk Yang/ Sungkyunkwan Uiniv., Korea |
| 13:40-13:55 | Current Status of Pediatric VAD Support | Iki Adachi/Texas Children’s Hospital, USA |
| 13:55-14:10 | The World Database for Pediatric and Congenital Heart Surgery: A Tool for Global Quality Improvement |
James D. St. Louis/ Children’s Mercy Hospital, USA |
| 14:10-14:30 | Discussion | |
| Heart Failure 3 | April 21, 14:40-16:00 Rm.103 | |
|---|---|---|
| Discuss with Cases | ||
| Chairpersons | 이상훈, 김재중 | |
| Panel | 박재형, 정진옥, 조상호, 한성우 | |
| 14:40-14:55 | Cardiac Sarcoidosis | 김은경/성균관의대 |
| 14:55-15:10 | Pulmonary Hypertension and RV Dysfunction | 최정현/부산의대 |
| 15:10-15:25 | Myocarditis | 김인철/계명의대 |
| 15:25-15:40 | Hypertropic Cardiomyopathy: Variable Manifestations | 장세용/경북의대 |
| 15:40-16:00 | Discussion | |
| [English Session] Basic Research 2 | April 21, 14:40-16:00 Rm.105 | |
|---|---|---|
| Cardiac Metabolism | ||
| Chairpersons | Myeong-Chan Cho, Sang Hong Baek | |
| Panel | Yong Sook Kim, Hyoung Kyu Kim, Pil-Ki Min, Hyun-Young Park, Sang-Hyun Ihm | |
| 14:40-14:55 | Ca2+ Regulation in Heart Failure | Steven R. Houser/Temple Univ., USA |
| 14:55-15:10 | Akt1 and Akt2 Are Required to Maintain Cardiac Contraction | Jaetaek Kim/Chung-Ang Univ., Korea |
| 15:10-15:25 | TRPC Channels in Cardiac Plasticity | Motohiro Nishida/ National Institutes of Natural Sciences, Japan |
| 15:25-15:40 | Angiotensin II Affects Inflammation Mechanisms via AMPK-Related Signalling Pathways in HL-1 Atrial Myocytes |
Hyeon Soo Kim/Korea Univ., Korea |
| 15:40-16:00 | Discussion | |
| [English Session] Pediatric Cardiac Surgery 2 | April 21, 14:40-16:00 Rm.107 | |
|---|---|---|
| Atrioventricular Valves | ||
| Chairpersons | Si Chan Sung, Tae Gook Jun | |
| Panel | Hyungtae Kim, Yu Rim Shin, Cheul Lee | |
| 14:40-14:52 | Surgical Options for Ebstein’s Anomaly | Tae-Jin Yun/Ulsan Univ., Korea |
| 14:52-15:04 | Management of TR in Patients with Repaired TOF | Chang-Ha Lee/ Sejong General Hospital, Korea |
| 15:04-15:16 | Surgical Options for Congenital Mitral Valve Diseases | Cheul Lee/Catholic Univ., Korea |
| 15:16-15:31 | Repair of Complete Atrioventricular Canal Defects: Surgical Techniques and Outcomes | James D. St. Louis/ Children’s Mercy Hospital, USA |
| 15:31-15:46 | Cardiac Recovery on VAD | Iki Adachi/Texas Children’s Hospital, USA |
| 15:46-16:00 | Discussion | |
| KHRS 1 | Apr.20(Fri) 09:30-11:00 Rm.202 | |
|---|---|---|
| ECG Interpretation: A Case-Based Review | ||
| Chairpersons | 이명용, 장성원 | |
| Case | 고점석, 김주연, 백용수, 신동금, 안진희, 이소령, 이혜영, 조영진 | |
| KHRS 2 | Apr.20(Fri) 11:10-12:40 Rm.202 | |
|---|---|---|
| Stroke Summit: Stroke Prevention and Anticoagulation | ||
| Chairpersons | 이만영, 최기준, 김대경 | |
| Panel | 김동혁, 배명환, 안민수, 이광노, 최영 | |
| 11:10-11:20 | Risk Stratification of Stroke and Thromboembolism in Atrial Fibrillation | 김태훈/연세의대 |
| 11:20-11:30 | Anticoagulation Guideline for Korean | 이정명/경희의대 |
| 11:30-11:40 | Characteristics of NOAC | 고점석/원광의대 |
| 11:40-11:50 | Selection Anticoagulation for High Bleeding Risk Patients | 이기홍/전남의대 |
| 11:50-12:00 | LAA Occluder | 임홍의/고려의대 |
| 12:00-12:15 | Asian Strategy for Stroke Prevention in Atrial Fibrillation | Tze-Fan Chao/ Taipei Veterans General Hospital, Taiwan |
| 12:15-12:40 | Discussion | |
| KHRS 3 | Apr.20(Fri) 14:30-16:00 Rm.202 | |
|---|---|---|
| AF Summit: Atrial Fibrillation | ||
| Chairpersons | 김영훈, 차태준, 김대혁 | |
| Panel | 김주연, 김준형, 김진배, 김진석, 박환철 | |
| 14:30-14:40 | Integrated Management of Atrial Fibrillation | 박준범/이화의대 |
| 14:40-14:50 | Rate Control of Atrial Fibrillation | 최의근/서울의대 |
| 14:50-15:00 | Rhythm Control of Atrial Fibrillation | 심재민/고려의대 |
| 15:00-15:10 | Outcomes of AF Ablation | 박희남/연세의대 |
| 15:10-15:20 | New Techniques for Atrial Fibrillation Ablation | 한성욱/계명의대 |
| 15:20-15:40 | Scar and Atrial Fibrillation | Nassir Marrouche/University of Utah, USA |
| 15:40-16:00 | Discussion | |
| KHRS 4 (부정맥-심부전 Joint Session) | Apr.21(Sat) 10:40-12:10 Rm.202 | |
|---|---|---|
| Device Therapy in Heart Failure | ||
| Chairpersons | 신동구, 최동주 | |
| Panel | 강석민, 노승영, 양필성, 홍석근 | |
| 10:40-10:50 | ICD and CRT - Benefit and Guideline | 이영수/대구가톨릭의대 |
| 10:50-11:00 | How to Select the Case for ICD and CRT? | 박재형/충남의대 |
| 11:00-11:10 | When Is Best Time to Refer Patient for CRT | 김계훈/전남의대 |
| 11:10-11:20 | Monitoring of HF Patients with Devices | 유병수/연세의대 |
| 11:20-11:30 | How to Prevent Inappropriate Shock? | 박승정/성균관의대 |
| 11:30-11:40 | ICD and CRT Are More Effective in Asian HF Patients? | 정보영/연세의대 |
| 11:40-11:50 | The Role of VT Ablation in the Latest Guideline | 박형섭/계명의대 |
| 11:50-12:10 | Discussion | |
| KHRS 5 | Apr.21(Sat) 13:10-14:30 Rm.202 | |
|---|---|---|
| PSVT and VT | ||
| Chairpersons | 오동진, 이문형, 오용석 | |
| Panel | 권창희, 박진규, 박형욱, 이대인, 장진근 | |
| 13:10-13:20 | The Efficient and Smart Methods for Diagnosis of SVT | 오세일/서울의대 |
| 13:20-13:30 | WPW, AVRT | 김성환/가톨릭의대 |
| 13:30-13:40 | EKG Localization: Outflow VT | 김진석/고려의대 |
| 13:40-13:50 | EKG Localization: Non-Outflow VT | 김유리/가톨릭의대 |
| 13:50-14:00 | Management of VT Without Structural Heart Disease | 박경민/성균관의대 |
| 14:00-14:10 | Management of VT With Structural Heart Disease | 남기병/울산의대 |
| 14:10-14:30 | Discussion | |
| KHRS 6 | Apr.21(Sat) 14:40-16:00 Rm.202 | |
|---|---|---|
| CIED and Sudden Cardiac Death | ||
| Chairpersons | 곽충환, 정병천, 김남호 | |
| Panel | 강기운, 김동민, 남궁준, 유희태, 한상진 | |
| 14:40-14:50 | Should Device-Detected AF Be Treated? | 윤남식/전남의대 |
| 14:50-15:00 | Solving Complication During CIED Followup | 김준/울산의대 |
| 15:00-15:10 | Management of CIED Infection and Lead Extraction | 박상원/세종병원 |
| 15:10-15:20 | New Technique in CIED: Subcutaenous ICD, Leadless Pacemaker, Etc | 성정훈/차의대 |
| 15:20-15:30 | Role of Genetic Testing in Arrhythmia | 최종일/고려의대 |
| 15:30-15:40 | Substrate and Risk Stratification in ARVD/C | 조용근/경북의대 |
| 15:40-16:00 | Discussion | |
| KSIC 1 | April 20, 14:30-16:00 Rm. 201 | |
|---|---|---|
| How to PCI: Lectures for Beginning Cardiologists | ||
| Chairpersons | 박승정, 황흥곤 | |
| Panel | 박헌식, 안성균, 윤경호, 이성윤, 최소연, 허승호 | |
| 14:30-14:45 | History of Interventional Cardiology  |
권현철/성균관의대 |
| 14:45-15:00 | Access Site Basics: Transfemoral and Transradial Accesses & Its Closure | 이봉기/강원의대 |
| 15:00-15:15 | What You See Is Not What You Get: Using Intravascular Imaging to Complement Angiography |
홍영준/전남의대 |
| 15:15-15:30 | Into the Heart: Catheter and Wire Selection |
이재환/충남의대 |
| 15:30-15:45 | Don't Be Panic: How to Manage Acute Complications |
전국진/부산의대 |
| 15:45-16:00 | Discussion | |
| KSIC II | April 20, 16:10-17:40 Rm. 201 | |
|---|---|---|
| Dr., I Have Chest Pain: Non-interventional Management | ||
| Chairpersons | 승기배, 안태훈 | |
| Panel | 김두일, 도준형, 이철환, 채제건, 최진호, 편욱범 | |
| 16:10-16:25 | Strategy of Non-invasive Testing |
홍순준/고려의대 |
| 16:25-16:40 | Antiplatelet Therapy, Before and After PCI |
박용휘/경상의대 |
| 16:40-16:55 | Optimal Management for Dyslipidemia | 김수중/경희의대 |
| 16:55-17:10 | Antianginal Treatment, The Art of Medical Therapy |
정영훈/경상의대 |
| 17:10-17:25 | NOAC after PCI in AF Patients | 배장환/충북의대 |
| 17:25-17:40 | Discussion | |
| KSIC III | April 21, 09:00-10:30 Rm. 201 | |
|---|---|---|
| Take the Next Step in PCI: Treating Complex and Higher-Risk Indicated Patients (CHIP) | ||
| Chairpersons | Seung Jea Tahk, Kyoo Rok Han | |
| Panel | Sang Wook Kim, Ung Kim, Hee Yeol Kim, Seok Kyu Oh, Jun-Hee Lee, Seung Hwan Han | |
| 09:00-09:15 | Using Imaging and Physiology Guidance in Higher Risk Patients | Jung-Min Ahn/Ulsan Univ., Korea |
| 09:15-09:30 | PCI in Calcified Lesions |
Byeong-Keuk Kim/Yonsei Univ., Korea |
| 09:30-09:45 | PCI in Bifurcation | Sunao Nakamura/ New Tokyo Hospital, Japan |
| 09:45-10:00 | PCI during AMI: Complete vs. Culprit-only Revascularization |
Joo-Yong Hahn/Sungkyunkwan Univ., Korea |
| 10:00-10:15 | PCI in SVG Lesions |
Seung-Woon Rha/Korea Univ., Korea |
| 10:15-10:30 | Discussion | |
| KSIC IV | April 21, 13:10-14:30 Rm. 201 | |
|---|---|---|
| TAVR and Beyond | ||
| Chairpersons | 정명호, 김효수 | |
| Panel | 고영국, 김주한, 박종선, 채인호, 최승혁 | |
| 13:10-13:23 | Future Indications of TAVR: Low Risk Patients, Younger Patients, Asymptomatic Patients | 유철웅/고려의대 |
| 13:23-13:36 | Medical Treatment After TAVR |
박덕우/울산의대 |
| 13:36-13:49 | Valve-in-valve TAVR: Technical Pearls and Outcomes | 김효수/서울의대 |
| 13:49-14:02 | Durability of TAVR Valve : Bench Test & Clinical Evidence Compared with SAVR | 장기육/가톨릭의대 |
| 14:02-14:15 | Transcatheter Mitral and Tricuspid Valve Therapies |
김준홍/부산의대 |
| 14:15-14:30 | Discussion | |
| KSIC V | April 21, 14:40-16:00 Rm. 201 | |
|---|---|---|
| Hemodynamic Support | ||
| Chairpersons | 윤정한, 김무현 | |
| Panel | 고윤석, 김원, 송영빈, 양태현, 정우영, 최동훈 | |
| 14:40-14:53 | IABP |
강시혁/서울의대 |
| 14:53-15:06 | ECMO | 박택규/성균관의대 |
| 15:06-15:19 | VAD | 정성호/울산의대 |
| 15:19-15:32 | Hemodynamic Support in CHIP: Provisional vs Routine |
강웅철/가천의대 |
| 15:32-15:45 | Future Devices for Mechanical Circulatory Support in Cardiogenic Shock and High-Risk PCI |
서석민/가톨릭의대 |
| 15:45-16:00 | Discussion | |
| KSE 1 | April 20, 14:30-16:00 Rm. 101 | |
|---|---|---|
| Issues Regarding Valvular Diseases | ||
| Chairpersons | 김기식, 윤호중 | |
| 14:30-14:50 | Echo-Doppler Evaluation in Aortic Stenosis | 홍그루/연세의대 |
| 14:50-15:10 | Echo-Doppler Evaluation in Aortic Regurgitation | 이상철/성균관의대 |
| 15:10-15:30 | Echo-Doppler Evaluation in Mitral Regurgitation | 김용진/서울의대 |
| 15:30-15:50 | Echo-Doppler Evaluation in Tricuspid Regurgitation | 김계훈/전남의대 |
| 15:50-16:00 | Discussion | |
| KSE 2 | April 20, 16:10-17:40 Rm. 101 | |
|---|---|---|
| Instructive Cases Assessed by Echo and Its Friends | ||
| Chairpersons | 송재관, 임세중 | |
| Panel | 박재형, 박태호, 송종민, 정해억, 조구영 | |
| 16:10-16:30 | Aortic Stenosis: Moderate or Severe? | 신성희/인하의대 |
| 16:30-16:50 | Aortic Regurgitation: When the Etiological Evaluation Is Critical | 황희정/경희의대 |
| 16:50-17:10 | Tricuspid Regurgitation: Surgery or Not? | 김학령/서울의대 |
| 17:10-17:30 | Prosthetic Valves: Normal or Abnormal? | 박성미/고려의대 |
| 17:30-17:40 | Discussion | |
| KSE 3 | April 21, 13:10-14:40 Rm. 101 | |
|---|---|---|
| Issues Regarding Hypertrophic Cardiomyopathy | ||
| Chairpersons | 김동수, 박승우 | |
| 13:10-13:30 | Overview of Hypertrophic Cardiomyopathy | 김형관/서울의대 |
| 13:30-13:50 | Myocardial and Non-myocardial Alterations Found in Hypertrophic Cardiomyopathy: Assessment with Echo and Its Friends |
김미정/가톨릭의대 |
| 13:50-14:10 | Differential Diagnosis of Hypertrophied Myocardium | 손일석/경희의대 |
| 14:10-14:30 | Surgical Treatment in Hypertrophic Cardiomyopathy: How, When, and Whom? | 김욱성/성균관의대 |
| 14:30-14:40 | Discussion | |
| KSE 4 | April 21, 14:40-16:10 Rm. 101 | |
|---|---|---|
| Instructive Cases Assessed by Echo and Its Friends | ||
| Chairpersons | 권준, 신준한 | |
| Panel | 박용현, 유승기, 윤현주, 조은주, 최의영 | |
| 14:40-15:00 | Hypertrophic Cardiomyopathy or Not? | 손정우/연세원주의대 |
| 15:00-15:20 | Restrictive Cardiomyopathy: Cardiac Amyloidosis and Its Mimics | 양동헌/경북의대 |
| 15:20-15:40 | Constrictive Pericarditis: Medical vs. Surgical. What's Your Choice? | 장성아/성균관의대 |
| 15:40-16:00 | Regional Wall Motion Abnormality: Ischemic vs. Non-ischemic. That's the Question! | 김경희/세종병원 |
| 16:00-16:10 | Discussion | |
| KSoLA 1 | April 20, 09:30-11:00 Rm. 107 | |
|---|---|---|
| Vascular Inflammation and Remodeling | ||
| Chairpersons | 김효수, 오구택 | |
| Panel | 박영미, 박종길, 조경현, 조현재, 한진 | |
| 09:30-09:50 | Role of Dendritic Cells in Vascular Inflammation |
최재훈/한양대 |
| 09:50-10:10 | Vessel Remodeling in Pulmonary Hypertension |
김종민/숙명여대 |
| 10:10-10:30 | Vessel Remodeling in Diabetic Retinopathy |
윤창환/서울의대 |
| 10:30-10:50 | Regulation of Atherosclerosis by Calpain Proteolytic Systems |
Takuro Miyazaki/Showa University, Japan |
| 10:50-11:00 | Discussion | |
| KSoLA 2 | April 20, 11:10-12:40 Rm. 107 | |
|---|---|---|
| Understanding Cardiometabolic Nutrition: A Cell to Neighborhood Perspective | ||
| Chairpersons | 서홍석, 이명숙 | |
| Panel | 강현재, 김상현, 김재택, 신민정, 이상학 | |
| 11:10-11:30 | Ectopic Olfactory Receptors Regulate Cellular Lipid Metabolism and Adiposity |
이성준/고려대 |
| 11:30-11:50 | Nutritional Systems Biology Approach for Understanding Homeostatic Protection of Botanical Phytochemicals Against Vascular Endothelial Dysfunction in Human Clinical Trials |
권오란/이화여대 |
| 11:50-12:10 | Social Determinant and Cardiometabolic Risks: Diet as a Mediator |
김오연/동아대 |
| 12:10-12:30 | Impact of Social Network Characteristics on Cardiometabolic Health |
김현창/연세의대 |
| 12:30-12:40 | Discussion | |
| KSoLA 3 | April 20, 13:40-14:30 Rm. 107 | |
|---|---|---|
| Debate Session ; Highly Intensive Lipid Lowering Therapy in DM without CVD - CV Risk and LDL-Cholesterol Target |
||
| Chairpersons | 이문규, 우정택 | |
| Panel | 김현민, 김혜진, 문민경, 박형규, 홍순준 | |
| 13:40-13:50 | Pros |
김재현/성균관의대 |
| 13:50-14:00 | Cons |
이우제/울산의대 |
| 14:00-14:10 | Rebuttals | |
| 14:10-14:30 | Discussion | |
| KSoLA 4 | April 20, 14:30-16:00 Rm. 107 | |
|---|---|---|
| Always Curious Questions ; Dyslipidemia and Atherosclerosis | ||
| Chairpersons | 정명호, 신현호 | |
| Panel | 김용재, 김학령, 서우근, 유태현, 임영효 | |
| 14:30-14:45 | New Promising Lipid-Modifying Drugs |
이용호/연세의대 |
| 14:45-15:00 | Lipid-Lowering Therapy in ESRD Patient |
장태익/국민건강보험공단 |
| 15:00-15:15 | Management of Insignificant Arterial Stenosis |
박광열/중앙의대 |
| 15:15-15:30 | Exercise for Cardiometabolic Health |
김영주/성신여대 |
| 15:30-15:45 | Sleep and Cardiovascular Disease |
양광익/순천향의대 |
| 15:45-16:00 | Discussion | |
| KSoLA 5 | April 20, 16:10-17:40 Rm. 107 | |
|---|---|---|
| Update session ; How to Interpret Recent CV Outcome Trials and Future Perspective | ||
| Chairpersons | 김치정, 박중열 | |
| Panel | 김주한, 박재형, 배지철, 이왕수, 이재혁 | |
| 16:10-16:25 | PCSK9 Inhibitors |
이은영/가톨릭의대 |
| 16:25-16:40 | What Do We Get from Recent Statin and CETP Inhibitors Trials? |
김병진/성균관의대 |
| 16:40-16:55 | How to Interpret Recent CV Outcome Trials and Future: SGLT2 Inhibitors/ DPP4 Inhibitors / GLP-1 Analogues |
정인경/경희의대 |
| 16:55-17:10 | NOACs in atherosclerotic CV disease |
최성훈/한림의대 |
| 17:10-17:40 | Discussion | |
| BEC 1 | April 21, 09:00-10:30 Rm.105 | |
|---|---|---|
| Meet the Experts of Biomedical Engineering Society for Circulation 1 | ||
| Chairpersons | 이상준, 이병권 | |
| Panel | 안예찬, 염은섭, 이계한, 이상형 | |
| 09:00-09:17 | 전산유체를 활용한 연성고체의 기계적 물성과 Rheology | 이준상/연세대 |
| 09:17-09:34 | Prediction of Plaque Progression Using FSI Simulation | 장혁재/연세의대 |
| 09:34-09:51 | CT-Derived Hemodynamics: Past, Present and Future | 구본권/서울의대 |
| 09:51-10:08 | In-vitro 4-D MRI를 이용한 경동맥협착증 수술 전후 혈류유동 비교 | 송시몬/한양대 |
| 10:08-10:30 | Discussion | |
| BEC 2 | April 21, 10:40-12:10 Rm.105 | |
|---|---|---|
| Meet the Experts of Biomedical Engineering Society for Circulation 2 | ||
| Chairpersons | 이계한, 김상욱 | |
| Panel | 송시몬, 유재영, 이상욱, 장혁재 | |
| 10:40-10:57 | Current Unmet Needs for Cerebro-Vascular Diseases | 이상형/서울의대 |
| 10:57-11:14 | Cerebral Venous Hemodynamics and Cerebrospinal Fluid | 심은보/강원대 |
| 11:14-11:31 | Hemorheologic Characteristics in Women According as Menstruation Cycle | 이병권/연세의대 |
| 11:31-11:48 | Diagnoses of Aged RBCs and Malaria with Holographic Microscopy & AI | 이상준/POSTECH |
| 11:48-12:10 | Discussion | |
| * POSTECH : Pohang University of Science and Technology | ||